Increasing demand for biopharmaceuticals and single-use products are some major driving factors for the global bioseparation systems market.
New York, NY -- (SBWIRE) -- 02/06/2017 -- Geographically, North America dominates the global bioseparation systems market. This is due to the improved life sciences research infrastructure and increasing demand for biopharmaceuticals in the region. In addition, technological advancements in equipment used in bioseparation procedures have also propelled the growth of the market in North America. The U.S. represents the largest market for bioseparation systems in North America, followed by Canada.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4735
In Europe, Germany, France, and the U.K. hold major shares of the bioseparation systems market. The bioseparation systems market in Asia too, is expected to show high growth rates over the next five years. This can be credited to the increasing demand for biopharmaceuticals in the region. In addition, many biopharmaceutical manufacturing companies are planning to construct their production units in Asian countries attracted by the less stringent regulations and low labor cost in the region. Growing population and economies of developing countries such as India and China are expected to steer the growth of the bioseparation systems market in Asia. Moreover, India, China, and Japan, are expected to be the fastest-growing markets for bioseparation systems in the region.
Increasing demand for biopharmaceuticals and single-use products are some major driving factors for the global bioseparation systems market. Also, technological advancements in equipment used in bioseparation and various initiatives taken by government organizations to increase awareness about therapeutic applications of biosimilars have propelled the growth of the global bioseparation systems market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4735
Stringent regulatory requirements for the approval of equipment used in bioseparation inhibit the growth of global bioseparation systems market. Rapid product launches and heightened mergers and acquisitions between medical device manufacturing companies are major trends observed in the global bioseparation systems market.
Key segments covered in this report are:
By type of bioseperation technology
Cell disruption technology
Pharmaceutical and biopharmaceutical
Top companies profiled in this report are:
GE Healthcare Life Sciences
US Filter Control Systems, Inc.
Asahi Kasei Corporation
Bio-Rad Laboratories, Inc.
Dow Chemical Company
Hitachi Koki Co LTD
ProMetic Life Sciences Inc.
SPECTRUM LABORATORIES, INC